Effect of electroacupuncture on post-caesarean section pain

Apriyanto,; Srilestari, Adiningsih; Abdurrohim, Kemas; Pryambodho,; Prasmusinto, Damar

doi:10.1088/1742-6596/1073/6/062038

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Particularly, anterior insula is an important area involved in visceral pain [24]. Low-frequency electroacupuncture stimulation using ST36 point has been shown to reduce allodynia pain where the effect is mediated by GABA spinal receptors [25]. The application of EA at ST36 point four within a week interval was shown to increase the number of NK cells, IFN-γ levels, Th1/Th2 ratio, appetite score and shrink tumor volume significantly, while also reducing pain scores and nausea and vomiting scores even though not significant [11].…”

Section: Discussionmentioning

confidence: 99%

The Effect of Electroacupuncture Therapy on Pain, Plasma β-Endorphin, and Quality of Life of Stage III Cervical Cancer Patients: A Randomized Control Trial

Saraswati

Wardani

Suhatno

et al. 2021

J Acupunct Meridian Stud

View full text Add to dashboard Cite

Background: Pain is a major complaint in cancer patients and a global problem that requires medical attention, including pain in cervical cancer. Although pharmacotherapy has been used for the treatment of cancer pain, there are still around 40% cannot be treated only with pharmacotherapy. Objectives: To determine the effects of electroacupuncture (EA) on pain in stage III cervical cancer patients. Methods: Twenty-eight stage III cervical cancer patients were divided into two groups (14 treatments and 14 controls) with randomized control trial design. The treatment group received EA with a frequency of 2/20-25 Hz at points of ST36, SP6, LI4 and LR3 for 30 minutes, while the control group did not receive EA. Both groups were given paracetamol and codeine at the same dose. Assessment was carried out by measuring pain scale (VAS), plasma β-endorphin levels, and quality of life/QoL (EORTC QLQ-C30) before and after therapy. Results: The average reduction in VAS in the treatment group (2.71 ± 1.14) compared to the control group (0.71 ± 1.33; p < 0.001), average increase in plasma β-endorphin levels in the treatment group (88.57 ± 52.46 pg/ml) compared to the control group (12.86 ± 56.76 pg/ml; p = 0.001), and in QoL, there were significant differences in symptom improvement between the treatment and control groups in the domain of fatigue, pain, insomnia and overall QoL (p < 0.05). Conclusion: Medical therapy combined with EA decreased pain scale, increased plasma β-endorphin levels, and improved the QoL for stage III cervical cancer patients.

show abstract

Section: Discussionmentioning

confidence: 99%